However, treatment with an anti-TNF-α antibody could mitigate the host response to P. gingivalis and reduce serum TNF-α, IL-6, blood glucose levels, and the size of the P. gingivalis inoculation lesion in a mouse model for type 2 diabetes and obesity [91]. This evidence concerns the gene TNF and obesity disorder.